Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Which Indices Are Most Followed By Investors highlights the benchmarks that attract the most attention from market participants and why their popularity matters.
27,878 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Netflix walks away from an $83 billion Warner Bros. deal, freeing capital for expansion and content, lifting the stoc...
A booming corner of lending shows signs of stress as liquidity tightens and defaults rise, with potential spillovers ...
Circle Internet Group posted a stronger-than-expected Q1 2026, triggering a 68% year-to-date gain and a rally that ou...
NextEra Energy announces a $67 billion all-stock deal to buy Dominion Energy, a move that could kick off a broader wa...
Energy markets are heating up as majors chase bolt-ons and long-life assets. Here are three smaller firms primed for ...
A veteran investor argues Talen Energy is undervalued versus its replacement cost, with potential for a doubling or m...
A 65-year-old with $1.4 million outlines a three-stock income plan focused on essential networks—defense, pipelines, ...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
Strategy (formerly MicroStrategy) appears poised to complete its 100th Bitcoin purchase, signaling a bold continuatio...
Valero Energy and Baker Hughes surge in 2026 on oil strength and refining margins, while First Solar pivots lower ami...
Funding pressures on the U.S. Postal Service are intensifying policy debate about last-mile delivery. Private carrier...